All studies
CompletedInterventional

MS-SMART: MS-Secondary Progressive Multi-Arm Randomisation Trial

Multiple sclerosis (MS) affects around 100,000 people across the UK. Many people with MS eventually develop secondary progressive MS (SPMS). In this phase, disability slowly builds up over time rather than coming in sudden flare-ups. Currently, there are very few treatments that protect nerves during this stage. The MS-SMART trial tests three medicines—amiloride, fluoxetine, and riluzole—that are already used safely for other health conditions. Researchers want to find out if any of these medicines can slow down nerve loss and brain shrinkage in people with SPMS. Around 440 adults aged 25 to 65 will take part across the UK. Participants are randomly chosen to take one of the three study medicines or a dummy tablet (placebo). Over 96 weeks, participants will take their tablets every day and attend clinic visits with MRI brain scans to monitor their progress.

At a glance

Status
Completed
Sponsor
University College London (UK)
Enrolment target
440
Start
18 Dec 2014
Estimated completion
22 Jun 2016

What is this study about?

Multiple sclerosis (MS) is a condition that affects the brain and spinal cord. In the early stages, known as relapsing remitting MS, people usually experience flare-ups of symptoms followed by periods of recovery. Over 10 to 15 years, however, many people move into a second phase called secondary progressive MS (SPMS). In this stage, symptoms like walking difficulties, poor balance, vision problems, and memory changes gradually increase over time without clear periods of recovery.

While there are effective treatments for early MS, finding treatments for the progressive stage is much harder. In SPMS, nerve fibres slowly become damaged and die off, which can cause the brain to shrink slightly faster than normal. There is an urgent need to find treatments that can protect these nerves from further harm.

The MS-SMART trial was designed to test three existing medicines: fluoxetine, riluzole, and amiloride. Because doctors already know these drugs well from treating other illnesses, testing them in MS is quicker and safer. The trial aims to see if any of these three medicines can shield nerve cells, slow down brain shrinkage, and help people stay mobile for longer compared to an inactive dummy treatment.

Key takeaways

  • Tests three existing medicines to see if they can protect brain nerves in secondary progressive MS.
  • Compares the active medicines against an inactive dummy pill (placebo).
  • Open to adults aged 25 to 65 with a diagnosis of SPMS and gradual disability progression.
  • Involves taking daily tablets and having periodic MRI scans over roughly two years (96 weeks).
  • Supported by the National Institute for Health Research (NIHR) across UK hospitals.

Who may be eligible?

This study is designed for adults aged 25 to 65 who have a confirmed diagnosis of secondary progressive MS (SPMS). To join, your disability must have gradually worsened over the previous two years rather than changing mainly due to sudden attacks or relapses. You should still be able to walk, either on your own or using walking aids such as sticks or crutches.

Because the study checks your brain using magnetic resonance imaging (MRI) scans, you must be able to have an MRI safely. People with certain metal devices, such as pacemakers or permanent hearing aids, will not be able to participate. You must also be able to understand the trial details and fill out study questionnaires.

Because the possible effects of these medicines on an unborn baby are not fully known, men and women who could have children must agree to use reliable contraception throughout the study and for six weeks afterwards. Women will also need to take a routine pregnancy test before starting.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am between 25 and 65 years of age.
  2. I have been diagnosed with secondary progressive MS (SPMS).
  3. My walking or other symptoms have slowly worsened over the last two years.
  4. I can walk independently or with the help of walking aids like sticks or crutches.
  5. I can safely have an MRI scan (I do not have a pacemaker or metallic implants).
  6. I am willing to use reliable contraception during the trial if pregnancy is possible.
Answer every question to see your result.

What does participation involve?

Taking part in the MS-SMART study lasts for about 96 weeks (nearly two years). If you decide to take part, a computer will assign you by chance to receive either one of the three active medicines or an inactive dummy pill (placebo). Neither you nor your study doctor can choose which pill you receive. You will take your assigned tablets each day at home. Over the two-year period, you will visit the hospital clinic regularly for check-ups. During these visits, doctors will assess your walking, test your thinking skills, and carry out MRI brain scans to see whether the treatment is protecting your nerve cells.

Potential risks and benefits

Taking part in this study may not directly cure your symptoms, but you will receive regular, close check-ups from MS specialist teams. The information gathered may also help doctors find new treatments for people with SPMS in the future. As with all medicines, there is a risk of side effects, which the medical team will discuss with you beforehand. There is also a one-in-four chance that you will receive a dummy pill with no active medicine. Taking part is completely your choice, and you are free to leave the trial at any time without giving a reason and without your normal NHS care being affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • Edinburgh Clinical Trials Unit
    City only
    Edinburgh, Scotland

Common questions

What is a placebo?

A placebo is a dummy pill that looks and tastes just like the real medicine but contains no active ingredients. It helps doctors see if any changes are truly caused by the study drug.

Can I choose which medicine I receive?

No. A computer assigns you to a group completely at random. This makes sure the test is fair and the scientific results are reliable.

Do I have to pay to take part?

No. Taking part in this NHS-supported study is free, and the trial medication is provided at no cost to you.

What does an MRI scan involve?

An MRI is a painless scan that uses magnets to create detailed pictures of your brain. You lie flat inside a scanner tunnel while the machine takes pictures. It can be noisy, so you will wear ear protection.

Can I leave the study if I change my mind?

Yes. You have the right to withdraw from the trial at any point, and your standard NHS medical treatment will carry on as normal.

How to find out more

Moira Ross

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.